1-deoxynojirimycin has been researched along with Experimental Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CL; Chen, TY; Chen, YP; Cheng, YL; Hsieh, CY; Huang, WC; Lin, CF; Lin, CM; Lin, YS; Lu, PJ; Tsai, CC; Tsao, CW; Tseng, PC; Wang, CY; Wang, SH | 1 |
| Chang, J; Chrest, FJ; Mueller, RA; Partis, RA; Passaniti, A; Pili, R | 1 |
| Awwad, M; Axelrod, HR; Gilman, SC; Strome, PG | 1 |
| Baldwin, SA; Bramwell, ME; Davies, A | 1 |
| Mercurio, AM | 1 |
| Gillette, RW; Long, CG; McKearn, TJ; Rodwell, JD; Simonson, RB; Ultee, ME | 1 |
6 other study(ies) available for 1-deoxynojirimycin and Experimental Neoplasms
| Article | Year |
|---|---|
Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis.
Topics: 1-Deoxynojirimycin; Animals; Apoptosis; Cell Line, Tumor; Ceramides; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Genes, abl; Glucosyltransferases; Glycogen Synthase Kinase 3; Humans; Immunoglobulin G; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melphalan; Mice; Mice, SCID; Morpholines; Mutation; Neoplasms, Experimental; Pyrimidines; Transplantation, Heterologous | 2011 |
The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.
Topics: 1-Deoxynojirimycin; Animals; Cell Adhesion; Cell Aggregation; Cell Differentiation; Cell Division; Cells, Cultured; Chemotaxis; Endothelium; Glucosamine; Glycoconjugates; Glycoside Hydrolase Inhibitors; Glycosylation; Growth Inhibitors; In Vitro Techniques; Indolizines; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Protein Processing, Post-Translational | 1995 |
Modification of monoclonal antibody carbohydrates by oxidation, conjugation, or deoxymannojirimycin does not interfere with antibody effector functions.
Topics: 1-Deoxynojirimycin; Animals; Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Carbohydrate Metabolism; Carbohydrates; Cells, Cultured; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Doxorubicin; Female; Humans; Immunoglobulin G; Immunotherapy; Mice; Mice, Nude; Mitogens; Neoplasm Transplantation; Neoplasms, Experimental; Oligopeptides; Oxidation-Reduction; Pentetic Acid; Periodic Acid; Spleen | 1994 |
Heterogeneity of the glucose transporter in malignant and suppressed hybrid cells.
Topics: 1-Deoxynojirimycin; Animals; Brain; Cell Line; Erythrocytes; Glucosamine; Glycosylation; Humans; Hybrid Cells; Immune Sera; Immunoblotting; Mannosidases; Mice; Monosaccharide Transport Proteins; Neoplasms; Neoplasms, Experimental; Proteins; Rats; Tumor Cells, Cultured; Tunicamycin | 1990 |
Disruption of oligosaccharide processing in murine tumor cells inhibits their susceptibility to lysis by activated mouse macrophages.
Topics: 1-Deoxynojirimycin; Animals; Cell Line; Female; Glucosamine; Glycoproteins; Macrophages; Mice; Neoplasm Proteins; Neoplasms, Experimental; Protein Processing, Post-Translational | 1986 |
Inhibition of mannosidase in hybridomas yields monoclonal antibodies with greater capacity for carbohydrate labeling.
Topics: 1-Deoxynojirimycin; Acetylglucosamine; Acetylglucosaminidase; Animals; Antibodies, Monoclonal; Antigens; Carbohydrates; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Glucosamine; Humans; Hybridomas; Indium Radioisotopes; Mannose; Mannosidases; Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase; Mice; Neoplasms, Experimental; Tumor Cells, Cultured | 1988 |